Bioton S.A. | Mutual Funds

Mutual Funds that own Bioton S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
701,983
0.82%
-3,429
0%
07/31/2018
DFA Emerging Markets Small Cap Series
539,811
0.63%
-20,177
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
313,879
0.37%
0
0%
04/30/2018
Polunin Funds - Emerg. Mkts. Small Cap
227,895
0.27%
60,789
0.46%
06/30/2017
Vanguard Emerging Markets Stock Index Fund
226,538
0.26%
-1,106
0%
07/31/2018
Pocztylion OFE
167,230
0.2%
236
0.04%
12/31/2015
Vanguard FTSE All World (ex-US) Small Cap
142,059
0.17%
0
0%
07/31/2018
PZU FIO Parasolowy - Akcji KRAKOWIAK
108,000
0.13%
0
0.1%
12/31/2016
PZU SFIO GI - Akcji Spolek Dywidendowych
71,990
0.08%
-48,437
0.25%
12/31/2016
PZU FIO Parasolowy - Stabilnego Wzrostu MAZUREK
60,000
0.07%
0
0.02%
06/30/2017

About Bioton

View Profile
Address
Macierzysz, ul. Poznanska 12
Warsaw MZ 05
Poland
Employees -
Website http://www.bioton.pl
Updated 07/08/2019
BIOTON SA engages in the manufacture and production of medicines and pharmaceutical substances. The company offers oral hypoglycemic drug, foot cream and human insulin. It operates through the following segment: BIOTON S.